Skip to content

The clinical application and comparative study of micro-ultrasound contrast imaging

The clinical application and comparative study of micro-ultrasound contrast imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092068
Enrollment
Unknown
Registered
2024-11-08
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

CKD group and normal renal function group:None

Sponsors

Zhongshan Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria for this study consist of two groups of participants: the CKD group and the normal renal function group. Participants in the CKD group must be adults aged 18 to 80 years who have been diagnosed with chronic kidney disease (GFR < 60 mL/min/1.73 m², persisting for more than 3 months, or with proteinuria/hematuria). They should have no history of acute kidney injury, renal replacement therapy, or kidney transplantation, and must be able to understand and comply with the study requirements, completing all follow-up visits and examinations. Participants in the normal renal function group must be adults aged 18 years or older with normal kidney function, undergoing contrast-enhanced ultrasound for non-kidney-related conditions (such as gallbladder or thyroid disease). They should also be able to understand and comply with the study requirements, completing all follow-up visits and examinations.

Exclusion criteria

Exclusion criteria: The exclusion criteria specify that the CKD group will exclude patients with severe dysfunction of other organs, recent acute kidney injury, medications affecting kidney function, active infections, a history of chronic infectious diseases or malignancy, as well as those with severe cognitive impairment, psychiatric disorders, current or recent participation in other clinical trials, allergy to UMI contrast agents, or pregnant/breastfeeding women. For the normal renal function group, individuals with abnormal kidney function or a history of kidney disease, those using medications that affect kidney function, those with severe cardiovascular disease or liver failure, pregnant/breastfeeding women, or individuals allergic to ultrasound contrast agents will be excluded.

Design outcomes

Primary

MeasureTime frame
microvessel density;microvessel curvature;

Countries

China

Contacts

Public ContactHong Han

Zhongshan Hospital of Fudan University

han.hong@zs-hospital.sh.cn+86 136 8197 2793

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026